Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.39 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.34 |
| ▸ | CACNB2 | Q08289 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30002745 | 0.93 | TSHR (0.55) | TSHRHIF1AEPAS1FAAHTRPV1 | |
| SCHEMBL21441792 | 0.91 | TSHR (0.46) | TSHRFAAHTRPV1 | |
| SCHEMBL11852322 | 0.91 | TSHR (0.59) | TSHRHIF1AEPAS1FAAHTRPV1 | |
| SCHEMBL11852320 | 0.91 | TSHR (0.59) | TSHRHIF1AEPAS1FAAHTRPV1 | |
| SCHEMBL30099488 | 0.91 | TSHR (0.59) | TSHRHIF1AEPAS1FAAHTRPV1 | |
| SCHEMBL23341565 | 0.88 | TSHR (0.56) | TSHRHIF1AEPAS1FAAHTRPV1 | |
| SCHEMBL11437767 | 0.88 | TSHR (0.56) | TSHRHIF1AEPAS1FAAHTRPV1 | |
| SCHEMBL2594701 | 0.88 | TSHR (0.56) | TSHRFAAHTRPV1 | |
| SCHEMBL22296738 | 0.88 | TSHR (0.56) | TSHRFAAHTRPV1 | |
| SCHEMBL11853973 | 0.88 | TSHR (0.56) | TSHRFAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9296768-B2 | Process for stabilizing hydrocyanation catalyst | INVISTA NORTH AMERICA S.A R.L. (US) | 2016-03-29 | — | — | US | disclosed |
| US-20150148556-A1 | PROCESS FOR STABILIZING HYDROCYANATION CATALYST | INVISTA NORTH AMERICA S.A R.L. (US) | 2015-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150148556-A1 | PROCESS FOR STABILIZING HYDROCYANATION CATALYST | GNPAT, HPD, DHPS | TSHR 4532/4885HIF1A 2407/4885EPAS1 2927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.